Zobrazeno 1 - 10
of 112
pro vyhledávání: '"Jacques, Orgiazzi"'
Autor:
Victor Vermot-Desroches, Kim Thia-Soui-Tchong, Perrine Raymond, Andrea Filip, Jacques Orgiazzi, Emmanuel Jouanneau, Caroline Froment Tilikete, Françoise Borson-Chazot, Romain Manet, Juliette Abeillon Du Payrat
Publikováno v:
Annales d'Endocrinologie.
Autor:
Anne-Sophie Gauchez, Magali Pizzo, Dany Alcaraz-Galvain, Karim Chikh, Jacques Orgiazzi, Georg Brabant, Catherine Ronin, Anne Charrié
Publikováno v:
Journal of Thyroid Research, Vol 2010 (2010)
Background. For unknown reasons, the prevalence of thyroid autoimmune disorders is higher in patients with Down's syndrome than in the general population. The present case strongly supports a recent evaluation of propagating screening for thyroid dis
Externí odkaz:
https://doaj.org/article/2c9dd3fbc5c040629e94a66bb7f7aa15
Autor:
Jacques Orgiazzi, Karim Chikh, Brigitte Delemer, Olivier Claris, Jacqueline Trouillas, Sara Barraud, Claire Schvartz, René Gabriel, Raymonde Bouvier, Jean Paul Bory, H. Grulet, Pierre François Souchon
Publikováno v:
Thyroid
Thyroid, Mary Ann Liebert, 2019, 29 (5), pp.743-747. ⟨10.1089/thy.2018.0098⟩
Thyroid, 2019, 29 (5), pp.743--747. ⟨10.1089/thy.2018.0098⟩
Thyroid, 2019, 29 (5), pp.743-747. ⟨10.1089/thy.2018.0098⟩
Thyroid, Mary Ann Liebert, 2019, 29 (5), pp.743-747. ⟨10.1089/thy.2018.0098⟩
Thyroid, 2019, 29 (5), pp.743--747. ⟨10.1089/thy.2018.0098⟩
Thyroid, 2019, 29 (5), pp.743-747. ⟨10.1089/thy.2018.0098⟩
International audience; Background: Thyroid-stimulating hormone (TSH) receptor (TSHR) antibodies (TRAb) can be present in chronic autoimmune thyroiditis. Transplacental TRAb transfer can lead to fetal thyroid dysfunction and serious complications. Pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10e81a492dd164f5c53c4dd231d7d8a0
https://hal.univ-reims.fr/hal-02327689
https://hal.univ-reims.fr/hal-02327689
Autor:
Antoine Hamy, Laurent Brunaud, Leila Bensalem Hachmi, Mourad Semrouni, Françoise Borson-Chazot, Bernard Corvilain, Charlotte Lussey-Lepoutre, Patrice Rodien, Jacques Orgiazzi
Publikováno v:
Annales d'endocrinologie. 79(6)
Treatment strategy in Graves' disease firstly requires recovery of euthyroid status by antithyroid therapy. Treatment modalities, precautions, advantages and side-effects are to be discussed with the patient. No particular treatment modality has demo
Autor:
George J Kahaly, Michaela Riedl, Jochem König, Susanne Pitz, Katharina Ponto, Tanja Diana, Elena Kampmann, Elisa Kolbe, Anja Eckstein, Lars C Moeller, Dagmar Führer, Mario Salvi, Nicola Curro, Irene Campi, Danila Covelli, Marenza Leo, Michele Marinò, Francesca Menconi, Claudio Marcocci, Luigi Bartalena, Petros Perros, Wilmar M Wiersinga, Göksun Ayvaz, Lelio Baldeschi, Kostas Boborides, Antonella Boschi, Thomas H Brix, Lucy Clarke, Colin Dayan, Chantal Daumerie, A Jane Dickinson, Nicole Fichter, Laszlo Hegedüs, Onur Konuk, Gerassimos E Krassas, Carol Lane, John Lazarus, Dan S Morris, Maarten. Mourits, Marco Nardi, Chris Neoh, Jacques Orgiazzi, Simon H S Pearce, Georg von Arx, Milos Zarkovic
Publikováno v:
Kahaly, G J, Riedl, M, König, J, Pitz, S, Ponto, K, Diana, T, Kampmann, E, Kolbe, E, Eckstein, A, Moeller, L C, Führer, D, Salvi, M, Curro, N, Campi, I, Covelli, D, Leo, M, Marinò, M, Menconi, F, Marcocci, C, Bartalena, L, Perros, P, Wiersinga, W M, European Group on Graves' Orbitopathy (EUGOGO), Hegedüs, L & Brix, T 2018, ' Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO) : a randomised, observer-masked, multicentre trial ', The Lancet Diabetes & Endocrinology, vol. 6, no. 4, pp. 287-298 . https://doi.org/10.1016/S2213-8587(18)30020-2
Lancet. Diabetes and endocrinology, 6(4), 287-298. Elsevier BV
Lancet. Diabetes and endocrinology, 6(4), 287-298. Elsevier BV
BACKGROUND: European guidelines recommend intravenous methylprednisolone as first-line treatment for active and severe Graves' orbitopathy; however, it is common for patients to have no response or have relapse after discontinuation of treatment. We
Autor:
Jacques Orgiazzi
Publikováno v:
Bulletin de l'Académie Nationale de Médecine. 197:43-63
Autor:
Chantal Daumerie, Jacques Orgiazzi
Publikováno v:
European Thyroid Journal, Vol. 7, no.4, p. 165-166 (2018)
Hyperthyroid Graves’ disease (GD) is an autoimmune thyroid disease caused by stimulating thyrotropin (TSH) receptor antibodies (TRAb). As early as the 1940s, the three components of the current therapeutic armamentarium for hyperthyroidism were alr
Autor:
Jacques Orgiazzi
Publikováno v:
La Presse Médicale. 41:e611-e625
This overview of the thyroid autoimmunity in human presents the various facets of a very common pathology. Focus is rather on fundamental than clinical aspects, although some specific clinical situations are discussed. Epidemiology, pathophysiology a
Autor:
Michael B. Zimmermann, Francine Claustrat, Françoise Borson-Chazot, Bruno Claustrat, Claire Bournaud, Véronique Raverot, Geneviève Sassolas, Jacques Orgiazzi, Pascal Gaucherand, Georges Mellier
Publikováno v:
Thyroid. 22:522-528
Iodine deficiency (ID) remains common in Europe, and may be especially detrimental during pregnancy. The aim of our study was to assess iodine status and thyroid function in healthy pregnant women in the Lyon metropolitan area.In a cross-sectional st